Myocardial Infarction

Adherence to guidelines results in better heart outcomes for diabetics

Published in Drug Week, October 1st, 2004

Improvement of treatment for ST-elevation myocardial infarction in diabetics according to guidelines reduced hospital mortality in clinical practice by 36% between 1994 and 2002, according to A.K. Gitt and colleagues at Herzzentrum Ludwigshafen, Ludwigshafen, Germany, speaking at the recent European Society of Cardiology Congress in Munich.

Diabetes mellitus increases the risk of developing coronary artery disease by a factor of 2-4. Cardiovascular complications are the leading causes of morbidity and mortality in patients with diabetes. In randomized controlled trials as well as in prospective registries, diabetics with acute ST-elevation myocardial infarction (STEMI)...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2004-10-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry